10,11-cyclopropyl-12-oxo-calanolide A | 1152308-78-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 10,11-cyclopropyl-12-oxo-calanolide A
• 英文别名: 10,10-dimethyl-6-propyl-3,9,15-trioxapentacyclo[12.5.0.02,7.08,13.016,18]nonadeca-1(14),2(7),5,8(13),11-pentaene-4,19-dione
• CAS: 1152308-78-5
• 化学式: C₂₁H₂₀O₅
• 分子量: 352.387
• InChiKey: AVTPWFGFXAGIEH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  61.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  1,1-二乙氧基-3-甲基-2-丁烯 、 8-Hydroxy-6-propyl-3,11-dioxatetracyclo[8.5.0.02,7.012,14]pentadeca-1(10),2(7),5,8-tetraene-4,15-dione 在 吡啶 作用下， 以 甲苯 为溶剂， 反应 1.5h， 以48%的产率得到10,11-cyclopropyl-12-oxo-calanolide A
  参考文献：
  名称：

  Highly Suppressing Wild-Type HIV-1 and Y181C Mutant HIV-1 Strains by 10-Chloromethyl-11-demethyl-12-oxo-calanolide A with Druggable Profile

  摘要：

  We herein report a new compound: 10-chloromethyl-11-demethyl-12-oxo-calanolide A (20, EC50 = 7.4 nM, St = 1417), which demonstrates a druggable profile with 32.7% oral bioavailability in rat, tolerated oral single dose toxicity in mice, and especially the feature of highly efficient suppression of the wild-type HIV-1 and Y181C mutant HIV-1 at an EC50 = 7.4 nM and EC50 = 0.46 nM, respectively.

  DOI：

  10.1021/jm901653e

文献信息

• TETRACYCLIC DIPYRANO-COUMARIN COMPOUNDS WITH ANTI-HIV AND ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITIES
  申请人：Liu Gang

  公开号：US20100324067A1

  公开（公告）日：2010-12-23

  The present invention relates to tetracyclodipyrano-coumarin compounds of general formula (I), wherein the substituents are defined herein. These compounds exihibit dual biological activities of anti human immunodeficiency virus type 1 (HIV-1) infection and anti- Mycobacterium Tuberculosis (TB) infection.

  本发明涉及通式（I）的四环二吡喃香豆素类化合物，其中取代基在此定义。这些化合物表现出抗人类免疫缺陷病毒类型1（HIV-1）感染和抗结核分枝杆菌（TB）感染的双重生物活性。
• TETRIACYCLODIPYRANYL COUMARINS AND THE ANTI-HIV AND ANTI-TUBERCULOSIS USES THEREOF
  申请人：Institute of Mataria Medica, Chinese Academy of Medical Sciences

  公开号：EP2216335A1

  公开（公告）日：2010-08-11

  The present invention relates to tctracyclodipyrano-coumarin compounds of general formula (I), wherein the substituents are defined herein. These compounds exihibit dual biological activities of anti human immunodeficiency virus type 1 (HIV-1) infection and anti-Mycobacterium Tuberculosis (TB) infection.

  本发明涉及通式(I)的三环二吡喃香豆素化合物，其中取代基在本文中定义。这些化合物具有抗人类免疫缺陷病毒 1 型（HIV-1）感染和抗结核分枝杆菌（TB）感染的双重生物活性。
• TETRACYCLODIPYRANYL COUMARINS AND THE ANTI-HIV AND ANTI-TUBERCULOSIS USES THEREOF
  申请人：Institute of Mataria Medica, Chinese Academy of Medical Sciences

  公开号：EP2216335B1

  公开（公告）日：2014-03-12